Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors

Journal of Medicinal Chemistry
Anthony A EstradaZachary K Sweeney

Abstract

Leucine-rich repeat kinase 2 (LRRK2) has drawn significant interest in the neuroscience research community because it is one of the most compelling targets for a potential disease-modifying Parkinson's disease therapy. Herein, we disclose structurally diverse small molecule inhibitors suitable for assessing the implications of sustained in vivo LRRK2 inhibition. Using previously reported aminopyrazole 2 as a lead molecule, we were able to engineer structural modifications in the solvent-exposed region of the ATP-binding site that significantly improve human hepatocyte stability, rat free brain exposure, and CYP inhibition and induction liabilities. Disciplined application of established optimal CNS design parameters culminated in the rapid identification of GNE-0877 (11) and GNE-9605 (20) as highly potent and selective LRRK2 inhibitors. The demonstrated metabolic stability, brain penetration across multiple species, and selectivity of these inhibitors support their use in preclinical efficacy and safety studies.

References

Jan 1, 1962·Pathologia et microbiologia·J J LALICH
May 22, 2004·Briefings in Bioinformatics·Amos BairochElisabeth Gasteiger
Sep 2, 2004·Neuron·Helen Tager-Flusberg
Nov 16, 2004·Neuron·Coro Paisán-RuízAndrew B Singleton
Apr 12, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Joseph Jankovic
May 12, 2005·Chemical Reviews·Michael E Jung, Grazia Piizzi
Nov 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Andrew B WestTed M Dawson
Apr 18, 2006·Trends in Neurosciences·Ignacio F MataKathleen A Gallo
Jun 6, 2006·Neurobiology of Disease·Elisa GreggioMark R Cookson
Jun 9, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xingrong LiuJeffrey Van Deusen
Jul 11, 2006·Journal of Medicinal Chemistry·George A Bray
Aug 24, 2006·Expert Opinion on Pharmacotherapy·Thomas Müller, Hermann Russ
Sep 28, 2006·Chembiochem : a European Journal of Chemical Biology·David Bednarski, Steven M Firestine
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·Marcella MartignoniRuben de Kanter
Dec 22, 2006·Journal of Medicinal Chemistry·Stephen A Hitchcock, Lewis D Pennington
May 9, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Y D GaoR T Mosley
Jan 29, 2008·Current Drug Metabolism·Jiunn H Lin
Nov 26, 2008·Journal of Neuroscience Research·Payal N GandhiAmy L Wilson-Delfosse
Feb 28, 2009·Nature Reviews. Drug Discovery·György M Keserü, Gergely M Makara
Jun 16, 2009·Lancet·Andrew J LeesTamas Revesz
Nov 17, 2009·Nature Genetics·Javier Simón-SánchezThomas Gasser
Feb 16, 2010·Bioorganic & Medicinal Chemistry Letters·Kurt ZimmermannDolatrai Vyas
May 12, 2010·Archives of Neurology·Justus C Dächsel, Matthew J Farrer
Nov 23, 2010·Nature Reviews. Neuroscience·Mark R Cookson
Mar 8, 2011·Nature Chemical Biology·Xianming DengNathanael S Gray
Sep 23, 2011·Journal of Medicinal Chemistry·Ed GriffenDaniel J Warner
Jan 11, 2012·Journal of Medicinal Chemistry·Akos TarcsayGyörgy M Keseru
Jan 13, 2012·Journal of Medicinal Chemistry·Dagmar Stumpfe, Jürgen Bajorath
Jan 19, 2012·Science Signaling·Patrick A Lewis, Claudia Manzoni
Feb 14, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xingrong LiuCornelis E C A Hop
Feb 16, 2012·Journal of Medicinal Chemistry·Klaus Müller
Feb 18, 2012·Bioorganic & Medicinal Chemistry Letters·Jinwei ZhangNathanael S Gray
Mar 16, 2012·Technology in Cancer Research & Treatment·Chaan S NgEdward F Jackson
Apr 11, 2012·Journal of Medicinal Chemistry·Jürgen Bajorath
Apr 12, 2012·Journal of Chemical Information and Modeling·Xiaoying HuJürgen Bajorath
Apr 18, 2012·Journal of Medicinal Chemistry·Stephen A Hitchcock
May 15, 2012·Trends in Pharmacological Sciences·Byoung Dae LeeTed M Dawson

❮ Previous
Next ❯

Citations

Dec 3, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Andrew B West
Apr 23, 2015·The FEBS Journal·Rebecca WallingsRina Bandopadhyay
Jun 12, 2014·Expert Opinion on Therapeutic Patents·Raghava R Kethiri, Rajagopal Bakthavatchalam
Feb 6, 2015·Science Translational Medicine·Reina N FujiRyan J Watts
May 19, 2016·European Journal of Medicinal Chemistry·Mohemmed Faraz KhanMohammad Shaquiquzzaman
Sep 16, 2016·Chemical Reviews·James A BullKate F Morgan
Feb 9, 2017·Future Medicinal Chemistry·Hendra GunosewoyoMichael Kassiou
Apr 27, 2017·Expert Opinion on Therapeutic Targets·Sharon L Chan, Eng-King Tan
Apr 30, 2017·Human Molecular Genetics·Marian Blanca RamírezSabine Hilfiker
Feb 23, 2017·Bioorganic & Medicinal Chemistry Letters·Min WangQi-Huang Zheng
Apr 11, 2015·Organic & Biomolecular Chemistry·K F MorganJ A Bull
Jan 13, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Khalid KarrouchiM'hammed Ansar
Oct 1, 2018·The European Journal of Neuroscience·Noémie CrestoEmmanuel Brouillet
Apr 20, 2019·Medicinal Research Reviews·Xiangyi JiangPeng Zhan
Jan 13, 2015·Clinical Chemistry and Laboratory Medicine : CCLM·Rutong RenXiaoping Pu
Sep 14, 2019·Future Medicinal Chemistry·Sofia DomingosRui Moreira
Feb 13, 2020·Expert Opinion on Therapeutic Patents·Xiao Ding, Feng Ren
Apr 12, 2020·Cells·Anna Adamiok-Ostrowska, Agnieszka Piekiełko-Witkowska
Jun 3, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anna Canela-XandriRamon Canela-Garayoa
Dec 4, 2016·Biochemical Society Transactions·Heather Mortiboys
Mar 16, 2017·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Noeen MalikYu-Shin Ding
Apr 24, 2020·Science Translational Medicine·Marco A S BaptistaTodd B Sherer
Oct 30, 2020·Frontiers in Aging Neuroscience·Caroline L Benn, Lee A Dawson
Jul 22, 2021·Computational and Structural Biotechnology Journal·Sarah Naomi BolzMichael Schroeder
Apr 29, 2015·Journal of Medicinal Chemistry·Anthony A Estrada, Zachary K Sweeney
Aug 24, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Andres E Leschziner, Samara L Reck-Peterson
Aug 28, 2021·Biomolecules·Dominika Natalia Wojewska, Arjan Kortholt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Bioorganic & Medicinal Chemistry Letters
Maurizio FranziniZhao Ren
Bioorganic & Medicinal Chemistry Letters
Albert W GarofaloZhao Ren
© 2021 Meta ULC. All rights reserved